Oncolytic measles vaccine virus MeV-SCD has previously demonstrated tumor-specific replication in experiments in human hepatoma and ovarian cancer cells (Hartkopf et al., 2013; Lampe et al., 2013). The gene discussed is SCD; the disease is neoplasm.